These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 28658515)

  • 1. Antipsychotic combinations for schizophrenia.
    Ortiz-Orendain J; Castiello-de Obeso S; Colunga-Lozano LE; Hu Y; Maayan N; Adams CE
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009005. PubMed ID: 28658515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium for schizophrenia.
    Leucht S; Helfer B; Dold M; Kissling W; McGrath JJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003834. PubMed ID: 26509923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
    Deng H; Xu J
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy for treatment-resistant schizophrenia.
    Sinclair DJ; Zhao S; Qi F; Nyakyoma K; Kwong JS; Adams CE
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011847. PubMed ID: 30888709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant treatments for schizophrenia.
    Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylsalicylic acid (aspirin) for schizophrenia.
    Schmidt L; Phelps E; Friedel J; Shokraneh F
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012116. PubMed ID: 31425623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment for antipsychotic-related constipation.
    Every-Palmer S; Newton-Howes G; Clarke MJ
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011128. PubMed ID: 28116777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepines for schizophrenia.
    Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acupuncture for schizophrenia.
    Shen X; Xia J; Adams CE
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005475. PubMed ID: 25330045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
    Ibragimov K; Keane GP; Carreño Glaría C; Cheng J; Llosa AE
    Cochrane Database Syst Rev; 2024 Jul; 7(7):CD013425. PubMed ID: 38958149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective noradrenaline reuptake inhibitors for schizophrenia.
    Matthews PRL; Horder J; Pearce M
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010219. PubMed ID: 29368813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpromazine versus piperacetazine for schizophrenia.
    Eslami Shahrbabaki M; Dehnavieh R; Vali L; Sharafkhani R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011709. PubMed ID: 30378678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia.
    Jones C; Hacker D; Meaden A; Cormac I; Irving CB; Xia J; Zhao S; Shi C; Chen J
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008712. PubMed ID: 30480760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
    Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.